Is single-agent temozolomide the treatment of choice for recurrent primary central nervous system lymphoma?
Omuro
Antonio M P
AM
Division de Neurologie, Groupe Hospitalier, Pitié-Salpêtrière, Mazarin 47, Paris, France. antonio.omuro@psl.aphp.fr